RhumbLine Advisers’s CG Oncology CGON Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.14M | Buy |
82,424
+7,735
| +10% | +$201K | ﹤0.01% | 1847 |
|
|
2025
Q1 | $1.83M | Buy |
74,689
+5,673
| +8% | +$139K | ﹤0.01% | 1850 |
|
|
2024
Q4 | $1.98M | Buy |
69,016
+1,458
| +2% | +$41.8K | ﹤0.01% | 1883 |
|
|
2024
Q3 | $2.55M | Buy |
67,558
+33,329
| +97% | +$1.26M | ﹤0.01% | 1773 |
|
|
2024
Q2 | $1.08M | Buy |
34,229
+3,940
| +13% | +$124K | ﹤0.01% | 2199 |
|
|
2024
Q1 | $1.33M | Buy |
+30,289
| New | +$1.33M | ﹤0.01% | 2102 |
|